End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | -4.37% | -4.37% | +12.42% |
23/05 | Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing | MT |
10/05 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.42% | 33Cr | |
+11.91% | 11TCr | |
+11.60% | 10TCr | |
-4.68% | 2.38TCr | |
-0.82% | 2.17TCr | |
-10.12% | 1.81TCr | |
-42.12% | 1.63TCr | |
-17.47% | 1.61TCr | |
+2.77% | 1.38TCr | |
+34.58% | 1.18TCr |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Zura Bio Partners With Benaroya Research Institute for Research on Immune-Mediated Disorders